期刊文献+

散血明目片对非缺血型视网膜静脉阻塞患者血液流变学的影响 被引量:3

Effect and mechanism of Sanxue Mingmu tablet on hemorheology in patients with non ischemic retinal vein occlusion
下载PDF
导出
摘要 目的探讨散血明目片对非缺血型视网膜静脉阻塞患者血液流变学及血清相关生化指标的影响及作用机制。方法将34例非缺血型视网膜静脉阻塞患者随机分为治疗组(17例17眼)与对照组(17例18眼),治疗组口服散血明目片,对照组口服血栓通片,两组均同时配合其他中西医常规治疗方法。治疗2个月后比较两组临床疗效、血液流变学及血清相关生化指标的差异。结果治疗组总显效率与对照组比较,差异有显著统计学意义(P<0.01);治疗组治疗前后低切和高切全血比黏度、红细胞电泳、血浆黏度、红细胞聚集指数、AT-Ⅲ、lp(a)、NO、A-CL IgG阳性率、ACL IgM阳性率、LA阳性率差异有显著统计学意义(P<0.01);ET-1、ACL IgA阳性率差异有统计学意义(P<0.05)。结论散血明目片是治疗非缺血型视网膜静脉阻塞的有效药物,其作用机制可能与升高AT-Ⅲ、降低lp(a)、APL在血浆中的含量、稳定ET-1/NO比值有关,在外可反映于血液流变学指标的变化。 Objective To investigate the effect and mechanism of Sanxue Mingmu tablet on hemorrheology and biochemical indicator related to blood-serum in patients with non ischemic retinal vein occlusion. Methods 34 patients were randomly divided into therapeutic group with 17 eyes in 17 patients, treated by Sanxue Mingmu tablet and control with group 18 eyes in 17 patients, treated by Xueshuantong tablet, both of them were combined with western medical treatment.The clinical effects would be compared the differences of hemorheology and biochemical indicator after one course of treatment. Results There was the significant statistical difference (P〈0.01) of the effective rate between the two groups; there were significant statistical differences(P〈0.01) of the low and high shear blood specific viscosity, erythrocyte eleetrophoresis, plasma viscosity and Erythrocyte aggregation; the significant statistical differences(P〈0.01) of the AT-III, lp(a) and NO, statistical difference(P〈0.05) of ET-1; significant statistical differences (P〈0.01) of ACL IgG,ACL IgM and LA positive rates; and the statistical differences (P〈0.05) of ACL IgA positive rate between before and after treatment in therapeutic group. Conclusions The tablet is effective drug for the non-ischemic retinal vein occlusion.The action mechanism may be related with increasing AT-III ,decreasing lp (a) and APL, stabilizing ET-1/NO.
出处 《湖南中医药大学学报》 CAS 2009年第5期57-60,共4页 Journal of Hunan University of Chinese Medicine
基金 湖南省科技厅科研基金资助项目(02SSY3096) 湖南省自然科学基金资助项目(06JJ50056)
关键词 散血明目片 活血通脉利水明目 视网膜静脉阻塞 血液流变学 血清生化指标 Sanxue Mingmu Tablet Promoting blood circulation and improving urine for vision retinal vein occlusion hemorheology serum biochemical indexes
  • 相关文献

参考文献9

二级参考文献53

  • 1周端,吴圣农,马贵同.“瘀可致水”理论的研究[J].中国医药学报,1989,4(1):8-11. 被引量:15
  • 2阮欣,国外医学.眼科分册,1994年,5卷,5期,286页
  • 3张勇进,眼底病杂志,1990年,6卷,3期,147页
  • 4张惠蓉,视网膜病临床和基础研究,1999年,84页
  • 5Fong ACO, Schatz H, McDonald HR, Burton TC, Maberley AL, Joffe L.Central retinal vein occlusion in young adults (papillophlebitis). Restina,1992;12:3-11
  • 6Bynoe LA, Weiss JN. Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol,2003; 135(3):382-384
  • 7Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol,2002;240(9):782-783
  • 8Ip M, Kahana A, Altaweel M. Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Semin Ophthalmol,2003; 18(2):67-73
  • 9Hayreh SS, Klgman MR, Beri M, Kimura AE, Podhajsky P. Differentiation of ischemic from nonischemic central retinal vein occlusion during the early acute phase. Graefes Arch Clin Exp Ophthalmol,1990;228:201-217
  • 10Paques M, Vallee JN, Herbreteau D, Aymart A, Santiago PY, Campinchi-Tardy F, Payen D, Merlan J J, Gaudric A, Massin P. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol,2000;84(12 ):1387-1391

共引文献275

同被引文献60

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部